InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Fenton Mary Kay, Chief Financial Officer. Director active across 1 companies, notably Talaris Therapeutics, Inc.. In total, 2 disclosures have been published. The latest transaction was filed on 31 December 2021 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
€11,4791,000 shares@ €11.479100.0% of flow
Common Stock
SEC:0000899243-22-004201·
€11,4791,000 shares@ €11.47950.0% of flow
Common Stock
SEC:0000899243-22-004201:0·
2 of 2 declarations
About Fenton Mary Kay
Mary Kay Fenton is the Chief Financial Officer at Talaris Therapeutics, Inc. She oversees the company's financial operations, ensuring compliance and risk management. Her expertise is essential for navigating the financial challenges the company faces.
